BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32139149)

  • 1. Risk of endometrial cancer among women with benign ovarian tumors - A Danish nationwide cohort study.
    Reinholdt K; Kjaer SK; Guleria S; Frederiksen K; Mellemkjær L; Munk C; Jensen A
    Gynecol Oncol; 2020 May; 157(2):549-554. PubMed ID: 32139149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast cancer among women with benign ovarian tumors: a Danish nationwide cohort study.
    Gottschau M; Jensen A; Reinholdt K; Guleria S; Munk C; Mellemkjær L; Kjær SK
    Breast Cancer Res Treat; 2019 Nov; 178(1):199-205. PubMed ID: 31364000
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of epithelial ovarian cancer among women with benign ovarian tumors: a follow-up study.
    Guleria S; Jensen A; Toender A; Kjaer SK
    Cancer Causes Control; 2020 Jan; 31(1):25-31. PubMed ID: 31673820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study.
    Gottschau M; Kjaer SK; Jensen A; Munk C; Mellemkjaer L
    Gynecol Oncol; 2015 Jan; 136(1):99-103. PubMed ID: 25451694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of borderline ovarian tumors among women with benign ovarian tumors: A cohort study.
    Guleria S; Jensen A; Kjær SK
    Gynecol Oncol; 2018 Jan; 148(1):86-90. PubMed ID: 29174556
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometriosis and risks for ovarian, endometrial and breast cancers: A nationwide cohort study.
    Mogensen JB; Kjær SK; Mellemkjær L; Jensen A
    Gynecol Oncol; 2016 Oct; 143(1):87-92. PubMed ID: 27430396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. First-time postmenopausal bleeding as a clinical marker of long-term cancer risk: A Danish Nationwide Cohort Study.
    Bengtsen MB; Veres K; Nørgaard M
    Br J Cancer; 2020 Feb; 122(3):445-451. PubMed ID: 31806879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tubal sterilization and risk of ovarian, endometrial and cervical cancer. A Danish population-based follow-up study of more than 65 000 sterilized women.
    Kjaer SK; Mellemkjaer L; Brinton LA; Johansen C; Gridley G; Olsen JH
    Int J Epidemiol; 2004 Jun; 33(3):596-602. PubMed ID: 15163640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endometrial cancer does not increase the 30-day risk of venous thromboembolism following hysterectomy compared to benign disease. A Danish National Cohort Study.
    Kahr HS; Christiansen OB; Høgdall C; Grove A; Mortensen RN; Torp-Pedersen C; Knudsen A; Thorlacius-Ussing O
    Gynecol Oncol; 2019 Oct; 155(1):112-118. PubMed ID: 31378374
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tibolone and risk of gynecological hormone sensitive cancer.
    Løkkegaard ECL; Mørch LS
    Int J Cancer; 2018 Jun; 142(12):2435-2440. PubMed ID: 29349823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
    Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
    Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence of ovarian cancer after hysterectomy: a nationwide controlled follow up.
    Loft A; Lidegaard O; Tabor A
    Br J Obstet Gynaecol; 1997 Nov; 104(11):1296-301. PubMed ID: 9386032
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subsequent primary malignancies after endometrial carcinoma and ovarian carcinoma.
    Hemminki K; Aaltonen L; Li X
    Cancer; 2003 May; 97(10):2432-9. PubMed ID: 12733142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk of nonovarian cancer in a nationwide-based study of nearly 5000 women with borderline ovarian tumors in Denmark.
    Hannibal CG; Baandrup L; Hertzum-Larsen R; Vang R; Kurman RJ; Frederiksen K; Kjaer SK
    Int J Cancer; 2023 Apr; 152(7):1370-1377. PubMed ID: 36366853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks of non-ovarian cancers in women with borderline ovarian tumor: a national cohort study in Sweden.
    Dobilas A; Jansåker F; Li X; Sundquist K; Borgfeldt C
    BMC Cancer; 2023 Oct; 23(1):951. PubMed ID: 37807065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer: A population-based cohort study in Taiwan.
    Ding DC; Chen W; Wang JH; Lin SZ
    Medicine (Baltimore); 2018 Sep; 97(39):e12608. PubMed ID: 30278576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of hormone therapies on type I and II endometrial cancer: A nationwide cohort study.
    Mørch LS; Kjaer SK; Keiding N; Løkkegaard E; Lidegaard Ø
    Int J Cancer; 2016 Mar; 138(6):1506-15. PubMed ID: 26421912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk for borderline ovarian tumours after exposure to fertility drugs: results of a population-based cohort study.
    Bjørnholt SM; Kjaer SK; Nielsen TS; Jensen A
    Hum Reprod; 2015 Jan; 30(1):222-31. PubMed ID: 25376453
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The preventable burden of endometrial and ovarian cancers in Australia: A pooled cohort study.
    Laaksonen MA; Arriaga ME; Canfell K; MacInnis RJ; Byles JE; Banks E; Shaw JE; Mitchell P; Giles GG; Magliano DJ; Gill TK; Klaes E; Velentzis LS; Hirani V; Cumming RG; Vajdic CM
    Gynecol Oncol; 2019 Jun; 153(3):580-588. PubMed ID: 30935715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Time trends in the incidence of hysterectomy-corrected overall, type 1 and type 2 endometrial cancer in Denmark 1978-2014.
    Faber MT; Frederiksen K; Jensen A; Aarslev PB; Kjaer SK
    Gynecol Oncol; 2017 Aug; 146(2):359-367. PubMed ID: 28545689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.